$80 Million Verdict in Transvaginal Mesh (Prolift) Trial
Updated: May 19, 2019
Yesterday, a Philadelphia jury tagged medical device maker Ethicon, a J&J subsidiary, with another hefty verdict ($80 million) in a case involving one of its transvaginal mesh devices, the Prolift. The plaintiff, Patricia Mesigian, had the device implanted in 2008 and brought claims against the company, including failure to warn, alleging that the device caused her chronic and permanent pain, infections, and scarring. She was represented at trial by lead counsel Tom Kline, of Kline & Specter, and this verdict comes just a month after Kline & Specter's $120 million verdict against Ethicon in a mesh case involving the TVT-O device.